VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
TAK
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
TAKTakeda Pharmaceutical Company Limited
$20.36$64.8B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksTAKQuarterly Cash Flow

Takeda Pharmaceutical Company Limited (TAK) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Takeda Pharmaceutical Company Limited (TAK) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

TAK Cash Flow Statement

Quarterly statement

TAK Cash Flow Statement

Takeda Pharmaceutical Company Limited (TAK) cash flow statement — 26-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Cash from Operations127.62B19.66B373.25B378.23B215.42B222.16B383.71B280.96B170.3B278.59B146.45B198.91B92.4B293.69B378.23B220.99B84.24B375.58B347.51B233.15B
Operating CF Margin %10.46%1.76%30.77%33.99%19.47%21.09%33.54%23.89%14.1%26.51%13.18%19.07%8.73%30.72%34.49%22.05%8.66%43.01%38.56%27.6%
Operating CF Growth %-40.76%-91.15%-2.73%34.62%26.49%-20.26%162.01%41.25%84.31%-5.14%-61.28%-9.99%9.69%-21.8%8.84%-5.22%-49.51%-6.33%59.44%-5.28%
Net Income113.2B-24.77B103.73B-11.73B124.28B-103.2B23.79B92.05B95.25B-3.02B105.75B-47.97B89.41B31.14B119.15B61.73B105.02B-11.38B57.82B45.99B
Depreciation & Amortization163.04B166.88B190.64B184.98B181.64B189.77B186.96B192.45B192.22B186.74B187.06B182.7B171.5B161.41B176.88B167.83B158.28B152.27B147.28B140.65B
Stock-Based Compensation18.19B017.8B18.73B16.53B17.63B18.3B21.55B15.39B18.19B18.71B18.54B15.44B14.85B16.49B17.04B12.29B11.32B11.09B12.43B
Deferred Taxes0030.13B39.9B26.35B-4.2B2.57B041.3B0-44.5B-48.01B45.63B16.78B-12B2.82B50.45B-42.67B14.37B15.45B
Other Non-Cash Items-8.14B102.06B70.28B124.4B-99.67B125.42B63.34B46.1B-93.66B-13.18B45.45B92.06B-78.63B-73.87B26.4B3.06B-53.34B87.36B34.73B7.85B
Working Capital Changes-158.66B-224.52B-39.33B21.94B-33.7B-7.46B88.76B-71.19B-80.19B89.86B-166.02B1.59B-150.95B143.39B51.3B-31.49B-188.47B178.68B82.22B10.78B
Change in Receivables-70.97B-103.74B-10.94B-9.8B48.08B-13.85B12.67B-10.04B-47.74B73.9B14.29B17.29B-90.37B68.27B12.77B12.05B-17.97B45.05B137.43B-13.36B
Change in Inventory-33.41B21.81B-37.96B-28.96B-13.07B-4.99B21.24B-41.14B-10.08B12.75B-50.55B-49.35B-28.59B-44.91B-18.46B-6.66B-9.12B-6.88B-14.3B-3.96B
Change in Payables05.27B000000-37.45B070.27B-15.02B-9.4B60.17B-7.71B-40.14B-141.28B128.5B00
Cash from Investing-87.7B-58.42B-229.8B-48.13B-33.19B-19.68B-115.56B-75.13B-156.69B-61.48B-75.27B-60.58B-266.53B-438.49B-46.69B-27.21B-94.71B-25.64B-69.14B-32.9B
Capital Expenditures-53.81B-57.97B-41.63B-40.09B-47.91B-48.79B-45.09B-49.47B-137.8B-44.54B-77.12B-70.04B-269.24B-444.08B-50.62B-40.61B-98.38B-51.82B-48.43B-30.76B
CapEx % of Revenue4.41%5.2%3.43%3.6%4.33%4.63%3.94%4.21%11.41%4.24%6.94%6.71%25.43%46.44%4.62%4.05%10.12%5.93%5.37%3.64%
Acquisitions0-402.43M3.36B417M29.29B67.65B1.26B02.95B0-26.25B-7M372M7.96B-15.02B-7.99B-55.61B26.06B-22.12B-10.64B
Investments--------------------
Other Investing-33.89B-1.04B-178.16B-9.79B-15.48B29.11B-7.72B-25.66B-14.18B-16.95B30.11B10.97B2.47B639M17.55B10.93B56.03B12M-570M-750M
Cash from Financing-180.35B-31.72B-192.45B-11.98B-214.9B-301.79B-655.97B-110.05B316.38B-58.22B-97.76B-140.66B-57.78B-6.6B-434.95B-51.88B-215.72B-243.8B-168.06B-247.37B
Debt Issued (Net)-11.29B-17.38B-9.89B36.55B22M-547.99B-470.88B230.45B429.61B-11.28B-96.51B-157.07B99.37B29.02B-266.2B-10.77B-37.13B-184.86B45.99B-208.36B
Equity Issued (Net)-1.01B1.32B00-51.6B-49.98B00-1.88B000-2.33B000-26.93B-24.99B-50B0
Dividends Paid-150.13B-1.53B-149.03B-8.79B-145.29B-9.74B-145.45B-9.2B-138.11B-9.13B-138.25B-9.06B-130.75B-10.42B-128.99B-11.13B-128.87B-10.64B-131.45B-9.54B
Share Repurchases-1.01B1.32B00-51.6B-49.98B00-1.88B000-2.33B000-26.93B-24.99B-50B0
Other Financing-17.92B-14.14B-33.53B-39.75B-18.02B305.92B-39.64B-331.3B26.76B-37.82B137B25.48B-24.07B-25.2B-39.77B-29.98B-22.79B-23.31B-32.6B-29.46B
Net Change in Cash-134.07B-69.98B-26.55B331.48B-35.1B-109.01B-364.94B54B347.21B169.44B-29.69B1.67B-217.15B-151.61B-113B152.15B-203.7B125.35B116.46B-47.04B
Free Cash Flow73.81B-26.01B150.88B325.4B140.35B173.37B327.06B231.49B112.86B234.05B69.33B128.86B-176.84B-150.39B327.61B180.38B-14.13B323.76B299.08B189.66B
FCF Margin %6.05%-2.33%12.44%29.24%12.68%16.46%28.59%19.68%9.34%22.27%6.24%12.35%-16.7%-15.73%29.88%18%-1.45%37.07%33.18%22.45%
FCF Growth %-47.41%-115%-53.87%40.57%24.36%-25.93%371.76%79.64%163.82%255.63%-78.84%-28.56%-1151.06%-146.45%9.54%-4.89%-111.35%12.03%71.55%-7.81%
FCF per Share23.00-8.3247.08103.1444.1954.81103.1771.8935.5174.6121.8741.16-56.50-46.59104.3157.68-4.55102.7394.9560.00
FCF Conversion (FCF/Net Income)1.13x-0.79x3.54x-32.05x1.73x-2.15x16.13x3.05x1.79x-92.31x1.39x-4.14x1.03x9.43x3.18x3.58x0.80x-33.07x6.02x5.07x
Interest Paid15.58B000034.88B35.81B0000000000000
Taxes Paid00000000000000000000